+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Fetal Alcohol Spectrum Disorder Treatment Market by Type (Alcohol-Related Birth Defects, Alcohol-Related Neurodevelopmental Disorder, Fetal Alcohol Syndrome), Treatment Type (Behavior & Education Therapy, Medication), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 185 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5977881
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Fetal Alcohol Spectrum Disorder Treatment Market grew from USD 370.13 million in 2023 to USD 387.75 million in 2024. It is expected to continue growing at a CAGR of 4.91%, reaching USD 518.04 million by 2030.

These effects include physical, behavioral, and learning issues. Treatment for FASD is multidisciplinary, involving interventions tailored to the individual’s specific needs. Common treatment approaches include medication to manage symptoms, behavioral therapies, education and school-based interventions, parent training, and social support services. The increasing awareness of FASD and the risks associated with alcohol consumption during pregnancy are major factors driving the expansion of treatment services. More healthcare practitioners are now equipped with the tools and knowledge to diagnose and manage FASD effectively. However, stigma and lack of understanding about FASD present barriers to accessing care. Nevertheless, development of more effective diagnostic tools that can detect disorders at an earlier stage. Furthermore, as societal awareness increases, there is potential for better preventative measures and educational programs aimed at reducing the incidence of FASD. Advances in therapy and care models, particularly those that incorporate technology and support broader access to resources, represent significant growth areas within the sector.

Regional Insights

The landscape for Fetal Alcohol Spectrum Disorder (FASD) treatment market in the Americas, particularly the United States and Canada, shows a developed landscape supported by higher awareness of FASD and governmental and non-governmental initiatives that focus on both prevention and management. These countries typically offer a range of services, including diagnostic, therapeutic, and support programs, which are often integrated into public health systems. In contrast, countries in the EMEA region exhibit diverse approaches due to varying healthcare policies and economic conditions. Western European countries generally have better-established healthcare systems that provide similar services as in the Americas, though the extent and effectiveness of these programs can vary. However, in parts of Eastern Europe, the Middle East, and Africa, resource constraints and lower awareness can limit the availability and quality of FASD treatments. The Asia Pacific region shows the greatest variation, with countries including Australia and New Zealand implementing comprehensive strategies akin to those in the West, while many Asian countries are still in the nascent stages of addressing FASD directly, often due to limited awareness and cultural differences in acknowledging alcohol-related disorders.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Fetal Alcohol Spectrum Disorder Treatment Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Increasing global prevalence of fetal alcohol spectrum disorders (FASD)
  • Advancements in diagnostic techniques and awareness programs
  • Support from regulatory bodies for research and development

Market Restraints

  • Challenges in diagnosis and standardization

Market Opportunities

  • Development of New Treatment Protocols and Guidelines
  • Initiation of supportive policies and funding models

Market Challenges

  • Complexities in product development and manufacturing

Market Segmentation Analysis

  • Type: High severity of fetal alcohol syndrome (FAS) causing physical and mental birth defect
  • End-User: Preferences for clinics as early screening and diagnosis point for FASD

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Fetal Alcohol Spectrum Disorder Treatment Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Fetal Alcohol Spectrum Disorder Treatment Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Enhancing Fetal Alcohol Spectrum Disorder Initiatives and Support in New Zealand

In response to the urgent need for improved support and recognition of Fetal Alcohol Spectrum Disorder (FASD), the New Zealand government has introduced comprehensive measures aimed at alleviating the condition's impact. The government’s plan includes the implementation of diagnostic training for health workers, the creation of a community-led support program for families and caregivers, and a national awareness campaign to prevent FASD. Additionally, the revitalization of the FASD Action Plan and the publication of new clinical diagnostic guidelines developed specifically for New Zealand's communities underscore the government's commitment.

Enhancing Fetal Alcohol Spectrum Disorder Strategies: A CAHS-Led Assessment Funded by Canadian Government

Recognizing the complexity and broad impacts of FASD, the Health Department of Canada has allocated approximately USD 950,000 to the Canadian Academy of Health Sciences (CAHS) to perform a thorough scientific evaluation of FASD. This assessment aims to comprehensively review existing data, literature, and current practices. It will also involve discussions with key stakeholders to pinpoint both obstacles and potential improvements to the national FASD strategy, thereby guiding future policy and intervention frameworks.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Fetal Alcohol Spectrum Disorder Treatment Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Fetal Alcohol Spectrum Disorder Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amneal Pharmaceuticals Inc., Cipla Ltd., Drukst Biotech Pvt. Ltd., Eli Lilly and Company, Elite Pharma Pvt. Ltd., Eris Lifesciences Ltd., GlaxoSmithKline PLC, Intas Pharmaceutical Ltd., Merck & Co. Inc., Pfizer Inc., Psychotropics India Ltd., RPG Life Sciences Ltd., SP Pharmaceuticals, and Wens Remedies Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Fetal Alcohol Spectrum Disorder Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type

  • Alcohol-Related Birth Defects
  • Alcohol-Related Neurodevelopmental Disorder
  • Fetal Alcohol Syndrome

Treatment Type

  • Behavior & Education Therapy
  • Medication

End-User

  • Clinics
  • Hospitals

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing global prevalence of fetal alcohol spectrum disorders (FASD)
5.1.1.2. Advancements in diagnostic techniques and awareness programs
5.1.1.3. Support from regulatory bodies for research and development
5.1.2. Restraints
5.1.2.1. Challenges in diagnosis and standardization
5.1.3. Opportunities
5.1.3.1. Development of New Treatment Protocols and Guidelines
5.1.3.2. Initiation of supportive policies and funding models
5.1.4. Challenges
5.1.4.1. Complexities in product development and manufacturing
5.2. Market Segmentation Analysis
5.2.1. Type: High severity of fetal alcohol syndrome (FAS) causing physical and mental birth defect
5.2.2. End-User: Preferences for clinics as early screening and diagnosis point for FASD
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Fetal Alcohol Spectrum Disorder Treatment Market, by Type
6.1. Introduction
6.2. Alcohol-Related Birth Defects
6.3. Alcohol-Related Neurodevelopmental Disorder
6.4. Fetal Alcohol Syndrome
7. Fetal Alcohol Spectrum Disorder Treatment Market, by Treatment Type
7.1. Introduction
7.2. Behavior & Education Therapy
7.3. Medication
8. Fetal Alcohol Spectrum Disorder Treatment Market, by End-User
8.1. Introduction
8.2. Clinics
8.3. Hospitals
9. Americas Fetal Alcohol Spectrum Disorder Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Fetal Alcohol Spectrum Disorder Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Fetal Alcohol Spectrum Disorder Treatment Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Enhancing Fetal Alcohol Spectrum Disorder Initiatives and Support in New Zealand
12.3.2. Enhancing Fetal Alcohol Spectrum Disorder Strategies: A CAHS-Led Assessment Funded by Canadian Government
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET DYNAMICS
FIGURE 7. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ALCOHOL-RELATED BIRTH DEFECTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ALCOHOL-RELATED BIRTH DEFECTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ALCOHOL-RELATED NEURODEVELOPMENTAL DISORDER, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ALCOHOL-RELATED NEURODEVELOPMENTAL DISORDER, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY FETAL ALCOHOL SYNDROME, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY FETAL ALCOHOL SYNDROME, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY BEHAVIOR & EDUCATION THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY BEHAVIOR & EDUCATION THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 28. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 29. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 30. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 35. ARGENTINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 36. ARGENTINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 37. ARGENTINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 38. ARGENTINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 41. BRAZIL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 42. BRAZIL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 43. BRAZIL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 44. BRAZIL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 47. CANADA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 48. CANADA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 49. CANADA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 50. CANADA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 51. CANADA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 52. CANADA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 53. MEXICO FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 54. MEXICO FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 55. MEXICO FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 56. MEXICO FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 57. MEXICO FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 58. MEXICO FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 59. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 60. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 61. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 62. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 68. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 70. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 75. AUSTRALIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 76. AUSTRALIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 77. AUSTRALIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 78. AUSTRALIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 81. CHINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 82. CHINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 83. CHINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 84. CHINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 85. CHINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 86. CHINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 87. INDIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 88. INDIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 89. INDIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 90. INDIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 91. INDIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. INDIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. INDONESIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 94. INDONESIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 95. INDONESIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 96. INDONESIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 99. JAPAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 100. JAPAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 101. JAPAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 102. JAPAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 103. JAPAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 104. JAPAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 105. MALAYSIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 106. MALAYSIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 107. MALAYSIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 108. MALAYSIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 111. PHILIPPINES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 112. PHILIPPINES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 113. PHILIPPINES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 114. PHILIPPINES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 117. SINGAPORE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 118. SINGAPORE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 119. SINGAPORE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 120. SINGAPORE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 123. SOUTH KOREA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 124. SOUTH KOREA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 125. SOUTH KOREA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 126. SOUTH KOREA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 129. TAIWAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 130. TAIWAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 131. TAIWAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 132. TAIWAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 135. THAILAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 136. THAILAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 137. THAILAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 138. THAILAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 139. THAILAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 140. THAILAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 141. VIETNAM FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 142. VIETNAM FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 143. VIETNAM FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 144. VIETNAM FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 155. DENMARK FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 156. DENMARK FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 157. DENMARK FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 158. DENMARK FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 159. DENMARK FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 160. DENMARK FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 161. EGYPT FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 162. EGYPT FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 163. EGYPT FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 164. EGYPT FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 165. EGYPT FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 166. EGYPT FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 167. FINLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 168. FINLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 169. FINLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 170. FINLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 171. FINLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 172. FINLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 173. FRANCE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 174. FRANCE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 175. FRANCE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 176. FRANCE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 177. FRANCE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 178. FRANCE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 179. GERMANY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 180. GERMANY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 181. GERMANY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 182. GERMANY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 183. GERMANY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 184. GERMANY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 185. ISRAEL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 186. ISRAEL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 187. ISRAEL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 188. ISRAEL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 191. ITALY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 192. ITALY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 193. ITALY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 194. ITALY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 195. ITALY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 196. ITALY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 197. NETHERLANDS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 198. NETHERLANDS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 199. NETHERLANDS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 200. NETHERLANDS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 203. NIGERIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 204. NIGERIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 205. NIGERIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 206. NIGERIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 209. NORWAY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 210. NORWAY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 211. NORWAY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 212. NORWAY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 213. NORWAY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 214. NORWAY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 215. POLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 216. POLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 217. POLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 218. POLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 219. POLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 220. POLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 221. QATAR FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 222. QATAR FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 223. QATAR FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 224. QATAR FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 225. QATAR FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 226. QATAR FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 227. RUSSIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 228. RUSSIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 229. RUSSIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 230. RUSSIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 234. SAUDI ARABIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 236. SAUDI ARABIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 240. SOUTH AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 242. SOUTH AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 245. SPAIN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 246. SPAIN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 247. SPAIN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 248. SPAIN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 249. SPAIN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 250. SPAIN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 251. SWEDEN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 252. SWEDEN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 253. SWEDEN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 254. SWEDEN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 257. SWITZERLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 258. SWITZERLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 259. SWITZERLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 260. SWITZERLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 263. TURKEY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 264. TURKEY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 265. TURKEY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 266. TURKEY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 267. TURKEY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 268. TURKEY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 276. UNITED KINGDOM FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 278. UNITED KINGDOM FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 281. FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 282. FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Fetal Alcohol Spectrum Disorder Treatment market, which are profiled in this report, include:
  • AbbVie Inc.
  • Amneal Pharmaceuticals Inc.
  • Cipla Ltd.
  • Drukst Biotech Pvt. Ltd.
  • Eli Lilly and Company
  • Elite Pharma Pvt. Ltd.
  • Eris Lifesciences Ltd.
  • GlaxoSmithKline PLC
  • Intas Pharmaceutical Ltd.
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Psychotropics India Ltd.
  • RPG Life Sciences Ltd.
  • SP Pharmaceuticals
  • Wens Remedies Pvt. Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 387.75 Million
Forecasted Market Value ( USD ) by 2030 $ 518.04 Million
Compound Annual Growth Rate4.9%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Neuroscience of Alcohol. Mechanisms and Treatment - Product Image

Neuroscience of Alcohol. Mechanisms and Treatment

  • Book
The Assessment and Treatment of Addiction. Best Practices and New Frontiers - Product Image

The Assessment and Treatment of Addiction. Best Practices and New Frontiers

  • Book
Global Alcohol Use Disorder Market by Treatment Type (Behavioral Therapy, Detoxification, Inpatient Rehabilitation), Disorder Type (Alcohol Abuse, Alcohol Dependence, High-Functioning Alcoholism), Distribution Channel - Forecast 2024-2030 - Product Image

Global Alcohol Use Disorder Market by Treatment Type (Behavioral Therapy, Detoxification, Inpatient Rehabilitation), Disorder Type (Alcohol Abuse, Alcohol Dependence, High-Functioning Alcoholism), Distribution Channel - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From
Alcohol Use Disorder - Pipeline Insight, 2024 - Product Image

Alcohol Use Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • 60 Pages
  • Global
Alcohol use disorder Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Image

Alcohol use disorder Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • 120 Pages
  • Asia Pacific
From

About the Fetal Alcohol Syndrome Drugs Market

Fetal Alcohol Syndrome (FAS) Drugs are a type of Central Nervous System (CNS) Drugs used to treat the physical and mental effects of prenatal alcohol exposure. These drugs are used to reduce the severity of physical and mental disabilities caused by FAS, such as facial deformities, growth deficiencies, and cognitive and behavioral problems. FAS Drugs are typically prescribed to pregnant women and infants, and may include medications to treat seizures, anxiety, and depression. FAS Drugs are a relatively new class of CNS Drugs, and research is ongoing to develop more effective treatments. Currently, there are no approved drugs specifically for FAS, but some medications used to treat other CNS conditions may be used off-label to treat FAS. Some companies in the Fetal Alcohol Syndrome Drugs market include Pfizer, GlaxoSmithKline, Merck, and Novartis. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.